Liminatus Pharma Warrants Total Liabilities

Liminatus Pharma Warrants (LIMNW) currently reports a total liabilities of $18M as of March 2022. That compares with $29M in the prior-year period — down 38.9% year over year. Use the charts on this page to explore Liminatus Pharma Warrants's total liabilities history and peer comparisons.

Liminatus Pharma Warrants's total liabilities decreased from $29M to $18M — a 38.9% year-over-year decrease (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Liminatus Pharma Warrants reported $18M in total liabilities as of March 2022. That compares with $29M in the prior-year period — down 38.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $18M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Liminatus Pharma Warrants, and consider following LIMNW for alerts when major investors trade the stock.